Aptamer Group H1 Revenue Up 27% on March 25 Report Aptamer Group reported a 27% rise in H1 revenue on 25 Mar 2026; the increase raises questions on revenue composition, margin conversion and sustainability.

Aptamer Group H1 Revenue Up 27% on March 25 Report: Aptamer Group reported a 27% rise in H1 revenue on 25 Mar 2026; the increase raises questions on revenue composition, margin conversion and… 👈 Read full analysis #AptamerGroup #RevenueGrowth #FinancialReport #BusinessInsights #CommercialSuccess

Aptamer Group Posts 27% Revenue Growth in 2026 Update Aptamer Group reported 27% YoY revenue growth on pharma contracts on 25 Mar 2026 (Investing.com); investors should await full financials for backlog and margin detail.

Aptamer Group Posts 27% Revenue Growth in 2026 Update: Aptamer Group reported 27% YoY revenue growth on pharma contracts on 25 Mar 2026 (Investing.com); investors should await full financials for backlog… 👈 Read full analysis #AptamerGroup #RevenueGrowth #PharmaInvesting #FinancialUpdate #Investing